- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 285/18 - 1,2,4-ThiadiazinesHydrogenated 1,2,4-thiadiazines
Patent holdings for IPC class C07D 285/18
Total number of patents in this class: 28
10-year publication summary
|
0
|
2
|
2
|
2
|
1
|
0
|
3
|
2
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Soleno Therapeutics, Inc. | 37 |
6 |
| Merck Sharp & Dohme LLC | 3736 |
6 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| CorMedix Inc. | 58 |
2 |
| Jacobs University Bremen gGmbH | 44 |
2 |
| Novartis AG | 10251 |
1 |
| F. Hoffmann-La Roche AG | 7819 |
1 |
| Centre National de La Recherche Scientifique | 11026 |
1 |
| Biophore India Pharmaceuticals Pvt. Ltd. | 92 |
1 |
| Cambridge Enterprise Limited | 1245 |
1 |
| Modernatx, Inc. | 1292 |
1 |
| University of Washington | 2447 |
1 |
| Westfaelische Wilhelms-universitaet Muenster | 47 |
1 |
| Westfalische Wilhelms-universitat Munster | 185 |
1 |
| Insilico Medicine IP Limited | 124 |
1 |
| Other owners | 0 |